Alan S. Roemer's Net Worth
-$231 Thousand
Who is Alan S. Roemer?
Alan S. Roemer does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include IN8BIO, INC., NexImmune, Inc., and Axovant Sciences Ltd..
SEC CIK
Alan S. Roemer's CIK is 0001643070
Past Insider Trading and Trends
2021 was Alan S. Roemer's most active year for acquiring shares with 10 total transactions. Alan S. Roemer's most active month to acquire stocks was the month of November. 2021 was Alan S. Roemer's most active year for disposing of shares, totalling 7 transactions. Alan S. Roemer's most active month to dispose stocks was the month of January. 2021 saw Alan S. Roemer paying a total of $245,866.59 for 301,955 shares, this is the most they've acquired in one year. In 2023 Alan S. Roemer cashed out on 106,037 shares for a total of $16,045.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IN8BIO, INC. (INAB) Snapshot price: $0.31
InvestorAlan S. Roemer owns 158,448 units of Common Stock which is worth $49,118.88. From 2021 to 2024 Alan S. Roemer acquired a total of 128,774 shares in IN8BIO, INC. at a cost of $49,998.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +183.00% | 102.46K |
—
|
—
| 158.45K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +88.68% | 26.32K |
$1.90 | $49,998.50 | 55.99K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NexImmune, Inc. (NEXI) Snapshot price: $0.371
InvestorAlan S. Roemer used to own units in Common Stock but no longer holds any shares there. In the year 2021 Alan S. Roemer filed a total of 8 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.83K |
$2.05 | -$16,045.38 |
0
|
Nov 21 - Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +52.86% | 67.66K |
$3.63 | $245,866.59 | 195.64K |
Dec 21
| |||
Form 4
|
∞
| 127.98K |
—
|
—
| 127.98K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.45
Principal Fin & Acct Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||